WallStreetZenWallStreetZen

NASDAQ: SINT
Sintx Technologies Inc Stock

Open Broker Account
$0.11-0.01 (-8.33%)
Updated Dec 5, 2022
SINT Price
$0.11
Fair Value Price
$0.30
Market Cap
$5.87M
52 Week Low
$0.08
52 Week High
$0.85
P/E
-0.28x
P/B
0.62x
P/S
8.24x
PEG
N/A
Dividend Yield
N/A
Revenue
$960.00k
Earnings
-$9.68M
Gross Margin
18.4%
Operating Margin
-1,007.4%
Profit Margin
-1,008.4%
Debt to Equity
0.55
Operating Cash Flow
-$11M
Beta
0.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SINT Overview

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SINT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SINT ($0.11) is undervalued by 62.82% relative to our estimate of its Fair Value price of $0.30 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SINT ($0.11) is significantly undervalued by 62.82% relative to our estimate of its Fair Value price of $0.30 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SINT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SINT due diligence checks available for Premium users.

Be the first to know about important SINT news, forecast changes, insider trades & much more!

SINT News

Valuation

SINT fair value

Fair Value of SINT stock based on Discounted Cash Flow (DCF)
Price
$0.11
Fair Value
$0.30
Undervalued by
63.80%
SINT ($0.11) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SINT ($0.11) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SINT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SINT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.28x
Industry
62.76x
Market
21.63x

SINT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.62x
Industry
3.76x
SINT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SINT's financial health

Profit margin

Revenue
$426.0k
Net Income
-$2.7M
Profit Margin
-639.4%
SINT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SINT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$14.6M
Liabilities
$5.1M
Debt to equity
0.55
SINT's short-term assets ($6.05M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SINT's short-term assets ($6.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SINT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SINT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.5M
Investing
-$510.0k
Financing
$0.0
SINT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SINT vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
SINT$5.87M-5.04%-0.28x0.62x
BIOL$5.87M-2.14%-0.23x0.42x
INBS$6.07M-4.89%-0.61x1.17x
BRSH$6.30M+0.39%N/A-0.72x
THMO$5.24M-4.20%-0.17x1.03x

Sintx Technologies Stock FAQ

What is Sintx Technologies's quote symbol?

NASDAQ: SINT) Sintx Technologies trades on the NASDAQ under the ticker symbol SINT. Sintx Technologies stock quotes can also be displayed as NASDAQ: SINT.

If you're new to stock investing, here's how to buy Sintx Technologies stock.

What is the 52 week high and low for Sintx Technologies (NASDAQ: SINT)?

(NASDAQ: SINT) Sintx Technologies's 52-week high was $0.85, and its 52-week low was $0.08. It is currently -86.67% from its 52-week high and 50.67% from its 52-week low.

How much is Sintx Technologies stock worth today?

(NASDAQ: SINT) Sintx Technologies currently has 51,933,095 outstanding shares. With Sintx Technologies stock trading at $0.11 per share, the total value of Sintx Technologies stock (market capitalization) is $5.87M.

Sintx Technologies stock was originally listed at a price of $29,106.29 in Feb 13, 2014. If you had invested in Sintx Technologies stock at $29,106.29, your return over the last 8 years would have been -100%, for an annualized return of -78.93% (not including any dividends or dividend reinvestments).

How much is Sintx Technologies's stock price per share?

(NASDAQ: SINT) Sintx Technologies stock price per share is $0.11 today (as of Dec 5, 2022).

What is Sintx Technologies's Market Cap?

(NASDAQ: SINT) Sintx Technologies's market cap is $5.87M, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sintx Technologies's market cap is calculated by multiplying SINT's current stock price of $0.11 by SINT's total outstanding shares of 51,933,095.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.